St. Jude Medical
From Wikipedia, the free encyclopedia
 |
The introduction to this article provides insufficient context for those unfamiliar with the subject. Please help improve the article with a good introductory style. |
| St. Jude Medical | |
|---|---|
| Type | Public (NYSE: STJ) |
| Founded | 1976 |
| Headquarters |  St. Paul, Minnesota |
| Key people | Daniel J. Starks, Chairman and CEO John C. Heinmiller, Executive Vice President & Chief Financial Officer |
| Industry | Medical device manufacturer |
| Net income | ▲ USD 548.25 million (2006) |
| Website | www.sjm.com |
St. Jude Medical, Inc. NYSE: STJ is a $2.9 billion global cardiovascular device company, with headquarters in St. Paul, Minnesota, United States. The company sells products in more than 100 countries and has over 20 operations and manufacturing facilities worldwide. Its principal competitors are Medtronic and Guidant, which was purchased in 2006 by Boston Scientific.
St. Jude Medical develops and manufactures the following products:
- Cardiac resynchronization therapy devices for heart failure
- Artificial pacemakers and implantable cardioverter defibrillators (ICDs) for treating cardiac rhythm disorders
- Diagnostic and therapeutic electrophysiology catheters
- Introducers, catheters, and vascular closure devices for cardiology and vascular access
- Mechanical and tissue heart valves plus valve repair products
- Spinal cord stimulators for intractable pain, through its subsidiary Advanced Neuromodulation System
[edit] External links
|
|||||||||||
 |
This article about a medical, pharmaceutical or biotechnological corporation or company is a stub. You can help Wikipedia by expanding it. |
